The research sheds light on a key cellular change that contributes to the malignancy of a common form of bone cancer, and which might aid in the development of biomarkers and therapeutic approaches to detect and treat this form of cancer.

Isidore Rigoutsos, PhD, a leader in the field of computational biology, has been named a Fellow of the American Association for the Advancement of Science (AAAS), in the Section of Biological Sciences.

As the only finalist in Philadelphia, and one of three hospital systems among the 7 candidates left, the Jefferson team now competes for a $1 million prize to use artificial intelligence (AI) in improving healthcare outcomes.

Jefferson researchers develop an approach to specifically impede the autoimmune response that drives the disease, while leaving the rest of the immune system fully functioning.  

Jefferson researchers develop an approach to specifically impede the autoimmune response that drives the disease, while leaving the rest of the immune system fully functioning.  

Research shows women are less likely to hear how cancer treatments might impact their sexual health. Experts weigh in on how women can explore these questions with their doctors and partners.   

Patients whose Type 2 diabetes is not controlled with metformin can benefit long-term from a two-drug combination treatment that also reduces weight. 

African American patients with lung cancer are still less likely to receive the most effective treatment for a common type of early stage lung cancer.